KCM
Kennedy Capital Management Portfolio holdings
AUM
$4.19B
1-Year Return
21.14%
This Quarter Return
-3.52%
1 Year Return
+21.14%
3 Year Return
+81.48%
5 Year Return
+215.31%
10 Year Return
+405%
AUM
$4.19B
AUM Growth
-$316M
(-7%)
Cap. Flow
-$53.8M
Cap. Flow
% of AUM
-1.28%
Top 10 Holdings %
Top 10 Hldgs %
8.69%
Holding
711
New
42
Increased
245
Reduced
345
Closed
69
Top Buys
| 1 |
Valmont Industries
VMI
|
$18.9M |
| 2 |
Upbound Group
UPBD
|
$13.6M |
| 3 |
Boot Barn
BOOT
|
$13.5M |
| 4 |
Bank OZK
OZK
|
$11.8M |
| 5 |
Alamo Group
ALG
|
$11.5M |
Top Sells
| 1 |
B
Barnes Group Inc.
B
|
$25.9M |
| 2 |
Mr. Cooper
COOP
|
$13.8M |
| 3 |
Veritex Holdings
VBTX
|
$13.5M |
| 4 |
VRNA
Verona Pharma
VRNA
|
$13.3M |
| 5 |
Huron Consulting
HURN
|
$10.9M |
Sector Composition
| 1 | Financials | 20.76% |
| 2 | Healthcare | 18.1% |
| 3 | Industrials | 18.07% |
| 4 | Technology | 12.65% |
| 5 | Consumer Discretionary | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
Tronox
TROX
$702M
| $130K | ﹤0.01% |
18,523
-135,989
| -88% | -$957K |
|
627
AXT Inc
AXTI
$150M
| $120K | ﹤0.01% |
85,245
-830,215
| -91% | -$1.17M |
|
628
Arcturus Therapeutics
ARCT
$476M
| $118K | ﹤0.01% |
11,130
+143
| +1% | +$1.51K |
|
629
Southland Holdings
SLND
$227M
| $108K | ﹤0.01% |
36,036
-6
| -0% | -$18 |
|
630
inTEST
INTT
$86.3M
| $101K | ﹤0.01% |
14,393
-80,676
| -85% | -$564K |
|
631
Immunome
IMNM
$890M
| $99.1K | ﹤0.01% |
14,725
+204
| +1% | +$1.37K |
|
632
Black Diamond Therapeutics
BDTX
$167M
| $98.5K | ﹤0.01% |
63,523
-370,270
| -85% | -$574K |
|
|
CMPS
633
Compass Pathways
CMPS
$481M
| $98.4K | ﹤0.01% |
34,415
+439
| +1% | +$1.26K |
|
634
Rocket Pharmaceuticals
RCKT
$346M
| $98.2K | ﹤0.01% |
14,725
-23,483
| -61% | -$157K |
|
635
Intellia Therapeutics
NTLA
$1.3B
| $92.5K | ﹤0.01% |
13,013
+166
| +1% | +$1.18K |
|
636
Cullinan Oncology
CGEM
$403M
| $88.1K | ﹤0.01% |
11,643
-99,406
| -90% | -$753K |
|
637
Design Therapeutics
DSGN
$362M
| $55.5K | ﹤0.01% |
14,383
+117
| +0.8% | +$452 |
|
638
Absci
ABSI
$383M
| – | – |
-102,995
| Closed | -$270K |
|
639
Ambarella
AMBA
$3.63B
| – | – |
-21,681
| Closed | -$1.58M |
|
640
ArcBest
ARCB
$1.72B
| – | – |
-19,444
| Closed | -$1.81M |
|
641
ARKO Corp
ARKO
$570M
| – | – |
-189,148
| Closed | -$1.25M |
|
642
Aspen Aerogels
ASPN
$545M
| – | – |
-224,475
| Closed | -$2.67M |
|
643
Amtech Systems
ASYS
$93.9M
| – | – |
-42,325
| Closed | -$231K |
|
644
Axon Enterprise
AXON
$58B
| – | – |
-356
| Closed | -$212K |
|
645
Popular Inc
BPOP
$8.46B
| – | – |
-8,554
| Closed | -$805K |
|
646
Bruker
BRKR
$4.6B
| – | – |
-49,388
| Closed | -$2.9M |
|
647
BrightView Holdings
BV
$1.36B
| – | – |
-148,125
| Closed | -$2.37M |
|
648
Cabot Corp
CBT
$4.24B
| – | – |
-8,573
| Closed | -$783K |
|
649
Columbus McKinnon
CMCO
$422M
| – | – |
-138,150
| Closed | -$5.14M |
|
650
Credo Technology Group
CRDO
$24.8B
| – | – |
-22,504
| Closed | -$1.51M |
|